Prevenar 13 Suspension for Injection (IM) פיליפינים - אנגלית - FDA (Food And Drug Administration)

prevenar 13 suspension for injection (im)

n/a; importer: pfizer, inc.; distributor: n/a - pneumococcal conjugate vaccine, 13-valent (adsorbed) - suspension for injection (im) - formulation: each 0.5 ml dose contains: pneumococcal polysaccharide serotype 1*.....2.2 mcg pneumococcal polysaccharide serotype 3*..............2.2 mcg pneumococcal polysaccharide serotype 4* ......... .............2.2 mcg pneumococcal polysaccharide serotype 5*..............2.2 mcg pneumococcal polysaccharide serotype 6a*............... ...2.2 mcg pneumococcal polysaccharide serotype 6b*........4.4 mcg pneumococcal polysaccharide serotype 7f*..........2.2 mcg pneumococcal polysaccharide serotype 9v* .........2.2 mcg pneumococcal polysaccharide serotype 14*.............2.2mcg pneumococcal polysaccharide serotype 18c*..............2.2 mcg pneumococcal polysaccharide serotype 19a* .....................2.2 mcg pneumococcal polysaccharide serotype 19f*....................2.2 mcg pneumococcal polysaccharide serotype 23f* .....................2.2 mcg *conjugated to crm197 carrier protein and adsorbed on aluminium phosphate (125 mcg aluminum)

SYNFLORIX SUSPENSION קנדה - אנגלית - Health Canada

synflorix suspension

glaxosmithkline inc - pneumococcal polysaccharide serotype 1 conjugated to protein d carrier protein; pneumococcal polysaccharide serotype 4 conjugated to protein d carrier protein; pneumococcal polysaccharide serotype 5 conjugated to protein d carrier protein; pneumococcal polysaccharide serotype 6b conjugated to protein d carrier protein; pneumococcal polysaccharide serotype 7f conjugated to protein d carrier protein; pneumococcal polysaccharide serotype 9v conjugated to protein d carrier protein; pneumococcal polysaccharide serotype 14 conjugated to protein d carrier protein; pneumococcal polysacc. serot. 18c conjug. to tetanus toxoid carrier prot.; pneumococcal polysaccharid serot. 19f conjug. to diphtheria toxoid carrier prot.; pneumococcal polysaccharide serotype 23f conjugated to protein d carrier protein - suspension - 1mcg; 3mcg; 1mcg; 1mcg; 1mcg; 1mcg; 1mcg; 3mcg; 3mcg; 1mcg - pneumococcal polysaccharide serotype 1 conjugated to protein d carrier protein 1mcg; pneumococcal polysaccharide serotype 4 conjugated to protein d carrier protein 3mcg; pneumococcal polysaccharide serotype 5 conjugated to protein d carrier protein 1mcg; pneumococcal polysaccharide serotype 6b conjugated to protein d carrier protein 1mcg; pneumococcal polysaccharide serotype 7f conjugated to protein d carrier protein 1mcg; pneumococcal polysaccharide serotype 9v conjugated to protein d carrier protein 1mcg; pneumococcal polysaccharide serotype 14 conjugated to protein d carrier protein 1mcg; pneumococcal polysacc. serot. 18c conjug. to tetanus toxoid carrier prot. 3mcg; pneumococcal polysaccharid serot. 19f conjug. to diphtheria toxoid carrier prot. 3mcg; pneumococcal polysaccharide serotype 23f conjugated to protein d carrier protein 1mcg - vaccines

Pneumovax 23 Pneumococcal Vaccine Polyvalent Solution for injection ערב הסעודית - אנגלית - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pneumovax 23 pneumococcal vaccine polyvalent solution for injection

merck sharp and dohme llc, united states - pneumococcal (streptococcus pneumoniae) polysaccharide (serotype 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f, 33f) - solution for injection - 50 µ/ml,

PNEUMOVAX 23 (PREFILLED SYRINGE) סינגפור - אנגלית - HSA (Health Sciences Authority)

pneumovax 23 (prefilled syringe)

msd pharma (singapore) pte. ltd. - pneumococcal polysaccharides 23 most prevalent types - injection - pneumococcal polysaccharides 23 most prevalent types 25mcg/0.5ml of each type

Synflorix Suspension for injection in PFS(Pneumococcal PolySccharide conjugated vaccine , adsorbed) - - ירדן - אנגלית - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

synflorix suspension for injection in pfs(pneumococcal polysccharide conjugated vaccine , adsorbed) - -

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - pneumococcal polysaccharide serotypes (11,2 , 41,2 ,51,2 ,6b1,2 ,7f1,2 ,9v1,2 ,141,2 ,18c1,3 ,19f1,4,23f1,2 ) - - - - -

VAXNEUVANCE ישראל - אנגלית - Ministry of Health

vaxneuvance

merck sharp & dohme (israel - 1996) company ltd, israel - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19 f; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 22f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 33f; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v - suspension for injection - pneumococcal polysaccharide serotype 33f 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 22f 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 23f 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19 f 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19a 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 18c 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 14 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 9v 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 7f 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6b 4.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6a 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 5 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 4 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 3 2.0 mcg / 0.5 ml; pneumococcal polysaccharide serotype 1 2.0 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older.the use of vaxneuvance should be in accordance with official recommendations

Pneumocon-13 Suspension for Injection (IM) פיליפינים - אנגלית - FDA (Food And Drug Administration)

pneumocon-13 suspension for injection (im)

n/a; importer: 2 world traders inc.; distributor: 2 world traders inc. - pneumococcal polysaccharide conjugate vaccine, 13- valent (adsorbed) - suspension for injection (im) - each dose (0.5 ml) contains the capsular polysaccharide of the following streptococcus pneumoniae serotypes: pneumococcal polysaccharide serotype 6b pneumococcal polysaccharide serotype 18c pneumococcal polysaccharide serotype 4, 23f pneumococcal polysaccharide serotype 7f pneumococcal polysaccharide serotype 14, 19f pneumococcal polysaccharide serotype 1, 19a 6.0 με 3.25 μg 3.0 με 2.85 με - 2.75 με 2.6 με pneumococcal polysaccharide serotype 3, 5, 6a, 9v conjugated to tetanus toxoid carrier protein 2.5 με 41-150 με

Pneumocon 13 Suspension for Injection (IM) פיליפינים - אנגלית - FDA (Food And Drug Administration)

pneumocon 13 suspension for injection (im)

n/a; importer: 2 world traders inc.; distributor: 2 world traders inc. - pneumococcal polysaccharide conjugate vaccine, 13- valent (adsorbed) - suspension for injection (im) - each dose (0.5 ml) contains the capsular polysaccharide of the following streptococcus pneumoniae serotypes: pneumococcal polysaccharide serotype 6b pneumococcal polysaccharide serotype 18c pneumococcal polysaccharide serotype 4, 23f pneumococcal polysaccharide serotype 7f pneumococcal polysaccharide serotype 14, 19f pneumococcal polysaccharide serotype 1, 19a pneumococcal polysaccharide serotype 3, 5, 6a, 9v conjugated to tetanus toxoid carrier protein 6.0 με 3.25 μg 3.0 με 2.85 μg 2.75 μg 2.6 μg

Prevenar 13 Suspension For Injection סינגפור - אנגלית - HSA (Health Sciences Authority)

prevenar 13 suspension for injection

pfizer private limited - crm197 protein; pneumococcal polysaccharide serotype 1 (conjugate); pneumococcal polysaccharide serotype 14 (conjugate); pneumococcal polysaccharide serotype 18c (conjugate); pneumococcal polysaccharide serotype 19a (conjugate); pneumococcal polysaccharide serotype 19f (conjugate); pneumococcal polysaccharide serotype 23f (conjugate); pneumococcal polysaccharide serotype 3 (conjugate); pneumococcal polysaccharide serotype 4 (conjugate); pneumococcal polysaccharide serotype 5 (conjugate); pneumococcal polysaccharide serotype 6a (conjugate); pneumococcal polysaccharide serotype 6b (conjugate); pneumococcal polysaccharide serotype 7f (conjugate); pneumococcal polysaccharide serotype 9v (conjugate) - injection, suspension - 32mcg - crm197 protein 32mcg; pneumococcal polysaccharide serotype 1 (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 14 (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 18c (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 19a (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 19f (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 23f (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 3 (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 4 (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 5 (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 6a (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 6b (conjugate) 4.4mcg; pneumococcal polysaccharide serotype 7f (conjugate) 2.2mcg; pneumococcal polysaccharide serotype 9v (conjugate) 2.2mcg

Hexavac האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

hexavac

sanofi pasteur msd, snc - purified diphtheria toxoid, purified tetanus toxoid, purified pertussis toxoid, purified pertussis filamentous haemagglutinin, hepatitis b surface antigen, inactivated type 1 poliovirus (mahoney), inactivated type 2 poliovirus (mef 1), inactivated type 3 poliovirus (saukett), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines - this combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis b caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by haemophilus influenzae type b.